Motor axon excitability during Wallerian degeneration

Brain

Volumn 132, Issue 2, 2009, Pages 511-523

  Moldovan, Mihai ^a   Alvarez, Susana ^a   Krarup, Christian ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Excitability; Internode; Ion channels; Nerve activity; Node of Ranvier; Regeneration

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CONTROLLED STUDY; CRUSH TRAUMA; ELECTROPHYSIOLOGY; FEMALE; MOTOR NERVE; MOUSE; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE DEGENERATION; NERVE EXCITABILITY; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; SODIUM CONDUCTANCE; TIBIAL NERVE;

ACTION POTENTIALS; ANIMALS; AXONS; AXOTOMY; CATS; FEMALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MOTOR NEURONS; NERVE DEGENERATION; TIBIAL NERVE; WALLERIAN DEGENERATION;

EID: 60149101523     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn332     Document Type: Article

References (58)

1. Alvarez S, Moldovan M, Krarup C. Acute energy restriction triggers Wallerian degeneration in mouse. Exp Neurol 2008; 212: 166-78.
2. Bachelard HS, Silva GD. The Na+,K+-activated adenosine triphosphatase in degenerating peripheral nerve. Arch Biochem Biophys 1966; 117: 98-105.
3. Baker MD. Axonal flip-flops and oscillators. Trends Neurosci 2000; 23: 514-19.
4. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 1982; 323: 117-44.
5. Bechtold DA, Smith KJ. Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J Neurol Sci 2005; 233: 27-35.
6. Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, et al. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 2005; 6: 6.
7. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol 1983; 341: 59-74.
8. Bostock H, Baker M, Grafe P, Reid G. Changes in excitability and accommodation of human motor axons following brief periods of ischaemia. J Physiol 1991; 441: 513-35.
9. Bostock H, Bergmans J. Post-tetanic excitability changes and ectopic discharges in a human motor axon. Brain 1994; 117: 913-28.
10. Bostock H, Burke D, Hales JP. Differences in behaviour of sensory and motor axons following release of ischaemia. Brain 1994; 117: 225-34.
11. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998; 21: 137-58.
12. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997; 498: 277-94.
13. Bostock H, Sears TA, Sherratt RM. The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J Physiol 1981; 313: 301-15.
14. Bostock H, Sharief MK, Reid G, Murray NM. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995; 118: 217-25.
15. Brismar T. Electrical properties of isolated demyelinated rat nerve fibres. Acta Physiol Scand 1981; 113: 161-6.
16. Burke D, Mogyoros I, Vagg R, Kiernan MC. Temperature dependence of excitability indices of human cutaneous afferents. Muscle Nerve 1999; 22: 51-60.
17. Chiu SY, Ritchie JM. On the physiological role of internodal potassium channels and the security of conduction in myelinated nerve fibres. Proc R Soc Lond B Biol Sci 1984; 220: 415-22.
18. Chiu SY, Ritchie JM, Rogart RB, Stagg D. A quantitative description of membrane currents in rabbit myelinated nerve. J Physiol 1979; 292: 149-66.
19. Gilliatt RW, Hjorth RJ. Nerve conduction during Wallerian degeneration in the baloon. J Neurol Neurosurg Psychiatry 1972; 35: 335-41.
20. Horn S, Quasthoff S, Grafe P, Bostock H, Renner R, Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve 1996; 19: 1268-75.
21. Ikegami K, Koike T. Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience 2003; 122: 617-26.
22. Kaji R. Physiological and technical basis of peripheral nerve and motoneuron testing. In: Kimura J, Kaji R, editors. Physiology of ALS and related diseases. Amsterdam: Elsevier Science; 1997. p. 15-41.
23. Kaji R, Sumner AJ. Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology 1989; 39: 1364-8.
24. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006; 129: 953-62.
25. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123: 2542-51.
26. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23: 399-409.
27. Kiernan MC, Cikurel K, Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain 2001; 124: 816-25.
28. Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005; 57: 339-48.
29. Kiernan MC, Lin CS, Burke D. Differences in activity-dependent hyperpolarization in human sensory and motor axons. J Physiol 2004; 558: 341-9.
30. Kiernan MC, Mogyoros I, Burke D. Changes in excitability and impulse transmission following prolonged repetitive activity in normal subjects and patients with a focal nerve lesion. Brain 1996; 119: 2029-37.
31. LoPachin RMJr, LoPachin VR, Saubermann AJ. Effects of axotomy on distribution and concentration of elements in rat sciatic nerve. J Neurochem 1990; 54: 320-32.
32. Lubinska L. Early course of Wallerian degeneration in myelinated fibres of the rat phrenic nerve. Brain Res 1977; 130: 47-63.
33. Lunn ER, Perry VH, Brown MC, Rosen H, Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1989; 1: 27-33.
34. Lyon MF, Ogunkolade BW, Brown MC, Atherton DJ, Perry VH. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc Natl Acad Sci USA 1993; 90: 9717-20.
35. Manjo G, Karnowsky ML. A biochemical and morphologic study of myelination and demyelination. II. Lipogenesis in vitro by rat nerves following transection. J Exp Med 1958; 108: 197-214.
36. Miledi R, Slater CR. On the degeneration of rat neuromuscular junctions after nerve section. J Physiol 1970; 207: 507-28.
37. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996; 119: 439-47.
38. Mogyoros I, Kiernan MC, Burke D, Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998; 121 (Pt 5): 851-9.
39. Mogyoros I, Lin C, Dowla S, Grosskreutz J, Burke D. Strength-duration properties and their voltage dependence at different sites along the median nerve. Clin Neurophysiol 1999; 110: 1618-24.
40. Moldovan M, Alvarez S, Krarup C. Excitability changes in distal motor axons undergoing Wallerian degeneration. J Neurol 2006; 253: 12.
41. Moldovan M, Krarup C. Mechanisms of hyperpolarization in regenerated mature motor axons in cat. J Physiol 2004a; 560: 807-19.
42. Moldovan M, Krarup C. Persistent abnormalities of membrane excitability in regenerated mature motor axons in cat. J Physiol 2004b; 560: 795-806.
43. Moldovan M, Krarup C. Excitability changes of cat tibial nerve during Wallerian degeneration. J Peripher Nerv Syst 2005; 10: 63.
44. Moldovan M, Krarup C. Evaluation of Na(+)/K(+) pump function following repetitive activity in mouse peripheral nerve. J Neurosci Methods 2006; 155: 161-71.
45. Okamoto M, Riker WFJr. Motor nerve terminals as the site of initial functional changes after denervation. J Gen Physiol 1969; 53: 70-80.
46. Ritchie JM, Straub RW. The hyperploarization which follows activity in mammalian non-medullated fibers. J Physiol 1957; 80-97.
47. Sawai S, Kanai K, Nakata M, Hiraga A, Misawa S, Isose S, et al. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration. Clin Neurophysiol 2008; 119: 1097-105.
48. Schwarz JR, Glassmeier G, Cooper EC, Kao TC, Nodera H, Tabuena D, et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier. J Physiol 2006; 573: 17-34.
49. Sievers C, Platt N, Perry VH, Coleman MP, Conforti L. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res 2003; 46: 161-9.
50. Skou JC. Enzymatic basis for active transport of Na+ and K+ across cell membrane. Physiol Rev 1965; 45: 596-617.
51. Tamura N, Kuwabara S, Misawa S, Kanai K, Nakata M, Sawai S, et al. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition. Clin Neurophysiol 2006; 117: 2451-8.
52. Tsao JW, Brown MC, Carden MJ, McLean WG, Perry VH. Loss of the compound action potential: an electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse. Eur J Neurosci 1994; 6: 516-24.
53. Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006; 117: 1458-66.
54. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations on the alterations produced thereby in the structure of their primitive fibers. Philos Trans R Soc Lond B Biol Sci 1850; 140: 423-9.
55. Weigl P, Bostock H, Franz P, Martius P, Muller W, Grafe P. Threshold tracking provides a rapid indication of ischaemic resistance in motor axons of diabetic subjects. Electroencephalogr Clin Neurophysiol 1989; 73: 369-71.
56. Williams PL, Hall SM. Prolonged in vivo observations of normal peripheral nerve fibres and their acute reactions to crush and deliberate trauma. J Anat 1971; 108: 397-408.
57. Winhammar JM, Rowe DB, Henderson RD, Kiernan MC. Assessment of disease progression in motor neuron disease. Lancet Neurol 2005; 4: 229-38.
58. Yokota T, Saito Y, Miyatake T. Conduction slowing without conduction block of compound muscle and nerve action potentials due to sodium channel block. J Neurol Sci 1994; 124: 220-4.